Literature DB >> 15343196

CD25+CD4+ regulatory T cells in patients with Kawasaki disease.

Kenji Furuno1, Tetsuji Yuge, Koichi Kusuhara, Hidetoshi Takada, Hisanori Nishio, Vahid Khajoee, Takuro Ohno, Toshiro Hara.   

Abstract

OBJECTIVE: To investigate whether the CD25 + CD4 + regulatory T-cell population, which plays important roles not only in maintaining immunologic self-tolerance but also in controlling the magnitude and character of antimicrobial immune responses, is related to the pathophysiology of Kawasaki disease (KD). STUDY
DESIGN: The patient group consisted of 54 patients (median age, 30 months; 27 female and 27 male patients) fulfilling the criteria for KD. Age-matched control subjects included 17 patients with active infections and 24 healthy children. We analyzed CD25 + CD4 + cells and the mRNA expression of Foxp3, cytotoxic T lymphocyte-associated antigen 4 (CTLA4), glucocorticoid-induced tumor necrosis factor receptor (GITR), and transforming growth factor beta in peripheral blood mononuclear cells and purified CD4 + T cells.
RESULTS: The proportions of CD25 + CD4 + cells in patients with acute-phase KD (median, 2.35% of total lymphocytes) were significantly lower than those in healthy control subjects (median, 3.14%) and control subjects with disease (median, 3.15%). The proportions returned to the normal level after intravenous gammaglobulin treatment (median, 3.86%). The mRNA expression of Foxp3, CTLA4, and GITR showed similar tendencies.
CONCLUSIONS: The decrease of CD25 + CD4 + regulatory T cells in the acute phase might have a role in the development of KD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15343196     DOI: 10.1016/j.jpeds.2004.05.048

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  29 in total

Review 1.  Immunomodulation by intravenous immunoglobulin: role of regulatory T cells.

Authors:  Mohan S Maddur; Shivashankar Othy; Pushpa Hegde; Janakiraman Vani; Sébastien Lacroix-Desmazes; Jagadeesh Bayry; Srini V Kaveri
Journal:  J Clin Immunol       Date:  2010-05       Impact factor: 8.317

Review 2.  T lymphocytes in Sjögren's syndrome: contributors to and regulators of pathophysiology.

Authors:  Gikas E Katsifis; Niki M Moutsopoulos; Sharon M Wahl
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

3.  Unique activation status of peripheral blood mononuclear cells at acute phase of Kawasaki disease.

Authors:  K Ikeda; K Yamaguchi; T Tanaka; Y Mizuno; A Hijikata; O Ohara; H Takada; K Kusuhara; T Hara
Journal:  Clin Exp Immunol       Date:  2009-12-15       Impact factor: 4.330

Review 4.  Regulatory T cells in human autoimmune diseases.

Authors:  Troy R Torgerson
Journal:  Springer Semin Immunopathol       Date:  2006-08-11

5.  CTLA-4, position 49 A/G polymorphism associated with coronary artery lesions in Kawasaki disease.

Authors:  Ho-Chang Kuo; Chi-Di Liang; Hong-Ren Yu; Chih-Lu Wang; I-Chun Lin; Chieh-An Liu; Jen-Chieh Chang; Chiu-Ping Lee; Wei-Chiao Chang; Kuender D Yang
Journal:  J Clin Immunol       Date:  2010-11-17       Impact factor: 8.317

6.  CD8+ T Cells Contribute to the Development of Coronary Arteritis in the Lactobacillus casei Cell Wall Extract-Induced Murine Model of Kawasaki Disease.

Authors:  Magali Noval Rivas; Youngho Lee; Daiko Wakita; Norika Chiba; Jargalsaikhan Dagvadorj; Kenichi Shimada; Shuang Chen; Michael C Fishbein; Thomas J A Lehman; Timothy R Crother; Moshe Arditi
Journal:  Arthritis Rheumatol       Date:  2017-02       Impact factor: 10.995

7.  Regulatory T cells and their role in rheumatic diseases: a potential target for novel therapeutic development.

Authors:  Diana Milojevic; Khoa D Nguyen; Diane Wara; Elizabeth D Mellins
Journal:  Pediatr Rheumatol Online J       Date:  2008-12-01       Impact factor: 3.054

8.  BTNL2 gene polymorphisms may be associated with susceptibility to Kawasaki disease and formation of coronary artery lesions in Taiwanese children.

Authors:  Kai-Chung Hsueh; Ying-Ju Lin; Jeng-Sheng Chang; Lei Wan; Fuu-Jen Tsai
Journal:  Eur J Pediatr       Date:  2009-11-01       Impact factor: 3.183

9.  Lack of CD4⁺CD25⁺FOXP3⁺ regulatory T cells is associated with resistance to intravenous immunoglobulin therapy in patients with Kawasaki disease.

Authors:  Yu Hirabayashi; Yoshiyuki Takahashi; Yinyan Xu; Kazuyuki Akane; Itzel Bustos Villalobos; Yusuke Okuno; Shinji Hasegawa; Hideki Muramatsu; Asahito Hama; Taichi Kato; Seiji Kojima
Journal:  Eur J Pediatr       Date:  2013-01-23       Impact factor: 3.183

10.  Patients treated with high-dose intravenous immunoglobulin show selective activation of regulatory T cells.

Authors:  A S W Tjon; T Tha-In; H J Metselaar; R van Gent; L J W van der Laan; Z M A Groothuismink; P A W te Boekhorst; P M van Hagen; J Kwekkeboom
Journal:  Clin Exp Immunol       Date:  2013-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.